These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 11109776)
1. [Riddles in human tuberculous infection]. Tsuyuguchi I Kekkaku; 2000 Oct; 75(10):603-9. PubMed ID: 11109776 [TBL] [Abstract][Full Text] [Related]
2. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
3. [Frontier of mycobacterium research--host vs. mycobacterium]. Okada M; Shirakawa T Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793 [TBL] [Abstract][Full Text] [Related]
4. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
10. Is adipose tissue a place for Mycobacterium tuberculosis persistence? Neyrolles O; Hernández-Pando R; Pietri-Rouxel F; Fornès P; Tailleux L; Barrios Payán JA; Pivert E; Bordat Y; Aguilar D; Prévost MC; Petit C; Gicquel B PLoS One; 2006 Dec; 1(1):e43. PubMed ID: 17183672 [TBL] [Abstract][Full Text] [Related]
11. [Distribution of antigenic glycolipids among Mycobacterium tuberculosis strains and their contribution to virulence]. Fujiwara N Kekkaku; 1997 Apr; 72(4):193-205. PubMed ID: 9145649 [TBL] [Abstract][Full Text] [Related]
12. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558 [TBL] [Abstract][Full Text] [Related]
13. [Mycobacterium tuberculosis virulence factors and its immune evasion mechanisms]. Colakoğlu S Mikrobiyol Bul; 2004; 38(1-2):155-67. PubMed ID: 15293916 [TBL] [Abstract][Full Text] [Related]
14. [Characteristics of a diagnostic method for tuberculosis infection based on whole blood interferon-gamma assay]. Harada N Kekkaku; 2006 Nov; 81(11):681-6. PubMed ID: 17154047 [TBL] [Abstract][Full Text] [Related]
16. Revisiting the natural history of tuberculosis. The inclusion of constant reinfection, host tolerance, and damage-response frameworks leads to a better understanding of latent infection and its evolution towards active disease. Cardona PJ Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):7-14. PubMed ID: 20049645 [TBL] [Abstract][Full Text] [Related]
17. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion. Sierra VG Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860 [TBL] [Abstract][Full Text] [Related]
18. [Exogenous re-infection in tuberculosis]. Tsuchiya T Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009 [TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set. Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808 [TBL] [Abstract][Full Text] [Related]
20. Virulence of Mycobacterium tuberculosis affects interleukin-8, monocyte chemoattractant protein-1 and interleukin-10 production by human mononuclear phagocytes. Fietta A; Meloni F; Francioli C; Morosini M; Bulgheroni A; Casali L; Gialdroni Grassi G Int J Tissue React; 2001; 23(4):113-25. PubMed ID: 11771775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]